Cure8 trial brief
Why This Matters
Work participation and job retention are common concerns for people living with IBD. This study will measure how IBD affects work ability, fatigue, mental health, and return-to-work barriers, and aims to create integrated clinical-occupational tools to support employment.
Who Should Pay Attention
Working-age people with IBD, occupational physicians, gastroenterology clinicians, rehabilitation specialists, employers, and researchers on work outcomes in chronic disease.
Study Snapshot
What To Know
This is a registered prospective multicenter observational study (MCNT@WORK) enrolling working-age adults with inflammatory bowel disease (Crohn's disease or ulcerative colitis) and a comparator group with breast cancer.
Participants will be assessed at baseline and after 12 months using integrated clinical, psychological, functional, and occupational measures to track work ability, absenteeism, presenteeism, quality of life, fatigue, stress, anxiety, and depression.
The study aims to identify clinical, psychosocial, and workplace factors linked to reduced work ability or barriers to return to work, and to develop an integrated clinical–occupational care pathway and practical tools (evaluation forms, checklists, and recommendations) to support job retention and safe return to work.
Keep In Mind
Registry entry / trial record describing study design and planned assessments. No results reported; the study will follow participants for 12 months to identify factors linked to work ability and to inform care pathways.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.